4Uriarte S M,Molestina R E,Miller R D,et al.Effect of macrolide antibiotics on human endothelial cells activated by chlamydia pneumonia infection and tumor necrosis factor-alpha[J].J Infect Dis,2002,185 (11):1631-1636.
5Doem G,Brueggemann A B,Huynh H,et al.Antimicobial resistance with Streptococus pneumoniate in the United States,1997-1998[J].Emerging Infect Dis,1999,5 (2):757-765.
6Schito G C,Marchese A,Elkharrat D,et al.Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae:results of two years of the PROTEKT surveiUance study[J].J Chemother,2004,16(1):13-22.
7Waites K,Brown S.Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern united states:data from the PROTEKT US surveillance program 2000/ 2001[J].South Med J,2003,96(10):974-985.
8Song J H,Chang H H,Suh J Y,et al.Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries:a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)[J].J Antimicrob Chemother,2004,53 (3):457-463.
9Leclereq R,Courvalin P.Resistance to macrolides and related antibiotics in Streptococcus pneumoniae[J].Antimicrob Agents Chenmother,2002,46(9):2727-2734.
10Van Eldere J,Meekers E,Lagrou K,et al.Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium[J].Clin Microbiol Infect,2005,11 (4):332-334.
4Nasa M, Choksey A, Phadke A, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pygori eradication: a randomized trial [J ]. Indian J Gastroenterol, 2013, 32(6) 392-396.
6Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
7Mccrory DC, Brown C, Gelfand SE, et al. Management of acute exacerbations of COPD: a summary and appraisal of published evidence[J]. Chest, 2001, 119(4): 1190-1209.
8Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part1[J]. Chest, 2001, 119(4): 1185-1189.
9Bierman KW, Morrow LE, Holweger JD, et al. Compliance with ATS-IDSA guideline recommendations for empiric antibiotic therapy in pneumonia[J]. Chest, 2010, 138(4): 856.
